Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of the Effect of Ketamine on Neurological Activity as Measured by Quantitative EEG

NCT05095792 is registered in ClinicalTrials.gov with Entheon Biomedical Corp. as lead sponsor.

NCT NCT05095792
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05095792 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of the Effect of Ketamine on Neurological Activity as Measured by Quantitative EEG
Lead sponsor
Entheon Biomedical Corp.
Phase
Observational
Overall status
Terminated
Start date
November 9, 2021
Completion date
October 21, 2022
Enrollment
1 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

treatment-resistant depression